Treatment of rheumatoid arthritis with a human recombinant interleukin 1 receptor antagonist;Behandlung der chronischen polyarthritis mit einem humanen rekombinanten interleukin-1-rezeptor-antagonisten

Zeitschrift fur Rheumatologie

Volumn 57, Issue 5, 1998, Pages 312-319

  Rau, R ^a   Sander, O ^a   Musikic, P ^a  

^a Evangelisches Fach krankenhaus Ratingen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; CONFERENCE PAPER; HUMAN; MAJOR CLINICAL STUDY; POLYARTHRITIS; RHEUMATOID ARTHRITIS; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS;

EID: 0031740179     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050118     Document Type: Conference Paper

References (36)

1. Arend WP, Dayer JM (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor in rheumatoid arthritis. Arthritis Rheum 38:151-160
2. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328:106-113
3. Chandrasekhar S, Harvey AK, Hrubey PS, Bendele AM (1990) Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol 55:382-394
4. van de Loo AAJ, van den Berg WB (1990) Effects of murine recombinant interleukin-1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 49:238-245
5. O'Byrne EM, Biancuzzi V, Wilson DE, Wong M, Jeng AY (1990) Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 33:1023-1028
6. van Beuningen HM, Arntz OJ, van den Berg WB (1991) In vivo effects of interleukin-1 on articular cartilage prolongation of proteoglycan metabolic disturbances in old mice. Arthritis Rheum 34:606-615
7. Hutchinson N, Lark MW, McNaul KL, Harper C, Hoerner LA, McDonnel J, Donatelli S, Moore V, Bayne EK (1992) In vivo expression of stromelysin in synovium and cartilage of rabbits injected intra-articularly with interleukin-1β. Arthritis Rheum 35:1227-1233
8. van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB (1995) Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage, proteoglycan metabolism and destruction: effect of in situ blocking of murine antigen- and zymosan-induced arthritis. Arthritis Rheum 38:164-172
9. Goto M, Fujisawa M, Yamada A, Okabe T, Takaku F, Sasano M, Nishiokka K (1990) Spontaneous release of angiotensin converting enzyme and interleukin-1 from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition. Ann Rheum Dis 49:172-176
10. Zangerle Pf, DeGroote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P (1992) Direct stimulation of cytokines (IL1β, TNF-α, IL6, IFNy and GM-CSF) in whole blood. II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4:568-575
11. Ruschen S, Tellbery W, Warnatz H (1992) Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls. Clin Exp Immunol 89:32-37
12. Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawele G (1992) Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 51:731-734
13. Thomas R, Carroll GJ (1993) Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 36:1244-1252
14. Rooney M, Symons JA, Duff GW (1990) Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 10:217-219
15. Firestein GS, Alvaro-Garcia JM, Maki R (1990) Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144:3347-3353
16. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RH (1992) Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 31:653-661
17. Wood NC, Dickens E, Symons JA, Duff GW (1992) In situ hybridisation of interleukin-1 in CD14 positive cells in rheumatoid arthritis. Clin Immunol Immunopathol 62:295-300
18. Firestein GS, Berge AE, Tracey DE, Chosay JG, Chapman DL, Pain MM, Yu C, Zvaifler NJ (1992) IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149:1054-1062
19. Koch AE, Kunkel SL, Chensue SW, Haines GK, Strieter RM (1992) Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin Immunol Immunopathol 64:23-29
20. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, Maini RN (1992) Localisation of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801-809
21. Arend WP, Welgus HG, Thompson RC, Eisenberg SP (1990) Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 85:1694-1697
22. Arend WP, Coll BP (1991) Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist binds to the 80-kDA IL-1 receptor but does not initiate IL1 signal transduction. J Biol Chem 266:10331-10336
23. Smith RJ, Chin JE, Sam LM, Justen JM (1991) Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1 stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 34:78-83
24. Seckinger P, Klein-Nulend J, Alander C, Thompson RC, Dayer JM; Raisz LG (1990) Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. J Immunol 145: 4181-4184
25. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP (1994) Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37:644-652
26. Campion GV, Lesback ME, Lookabaugh J, Gordon G, Catalano M and the IL-1 ra Arthritis Study Group (1996) Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 39:1092-1101
27. Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662
28. Felson DT, Anderson JJ, Boers M, Bombardieri C, Chemoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36: 729-740
29. Paulus HE, Egger MJ, Ward JR, Williams HJ and the Cooperative Systematic Studies of Rheumatic Disease Group (1990) Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on findings in patients treated with placebo. Arthritis Rheum 33:477-484
30. Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 18:481-491
31. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB (1996) Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNFα, anti-IL 1-b and IL-I ra. Arthritis Rheum 39:797-809
32. Henderson B, Thompson RC, Hardingham T, Lewthwaite J (1991) Inhibition of interleukin-1 induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 3:246-249
33. Wooley PH, Whalen JD, Chapman DC, Berger AE, Richard KA, Aspar DG, Staite ND (1993) The effect of interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 36:1305-1314
34. Lewthwaite J, Blake SM, Hardingham TE, Warden PJ, Henderson B (1994) The effect of recombinant human interleukin-1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J Rheumatol 21:467-472
35. Otani K, Nita I, Macauley W, Georgescu HI, Robbins PD, Evans CH (1996) Suppression of antigen-induced arthritis in rabbits by ex-vivo gene therapy. J Immunol 156:3558-3562
36. Collins D, McAbe T, Woodward M, Frazier J, Chipala E, Bendele A (1997) A slow release formulation of interleukin-1 receptor antagonist (IL-1 ra) exhibits improved in vivo activity. Arthritis Rheum 40:S180